Patent applications and USPTO patent grants for Wang; Yaling.The latest application filed is for "support structure member and display device".
Patent | Date |
---|---|
Support Structure Member And Display Device App 20220300038 - Wang; Yaling ;   et al. | 2022-09-22 |
Aspartase mutant, recombinant expression vector and recombinant bacterium containing aspartase mutant, and use thereof Grant 10,865,404 - Rao , et al. December 15, 2 | 2020-12-15 |
Pixel Arrangement Structure Of Display Panel And Display Apparatus App 20200357864 - XIAO; Zhihui ;   et al. | 2020-11-12 |
Gene targeting using mutant Agrobacterium strains Grant 10,526,611 - Gelvin , et al. J | 2020-01-07 |
One Lumbar Zero-profile Fusion System App 20190076265 - Subert; Lubomir ;   et al. | 2019-03-14 |
Minimally invasive screw with double threaded plugs Grant 10,022,156 - Zhang , et al. July 17, 2 | 2018-07-17 |
Minimally Invasive Screw With Double Threaded Plugs App 20170290607 - Zhang; Wenzhi ;   et al. | 2017-10-12 |
Gene Targeting Using Mutant Agrobacterium Strains App 20170022511 - Gelvin; Stanton B ;   et al. | 2017-01-26 |
Processes for preparing protease inhibitors of hepatitis C virus Grant 8,637,449 - Song , et al. January 28, 2 | 2014-01-28 |
Process for producing bicycloaniline derivatives Grant 8,507,504 - Furukawa , et al. August 13, 2 | 2013-08-13 |
Processes For Preparing Protease Inhibitors Of Hepatitis C Virus App 20120232247 - Song; Zhiguo Jake ;   et al. | 2012-09-13 |
Process For Producing Bicycloaniline Derivatives App 20110092520 - Furukawa; Shuntaro ;   et al. | 2011-04-21 |
Tyrosine kinase inhibitors Grant 7,893,081 - Avalle , et al. February 22, 2 | 2011-02-22 |
Synthesis and crystalline forms of NPY5 antagonist Grant 7,700,611 - Ferlita , et al. April 20, 2 | 2010-04-20 |
Formation Of Tetra-substituted Enamides And Stereoselective Reduction Thereof App 20100041893 - CAMPOS; KEVIN R. ;   et al. | 2010-02-18 |
Formation of tetra-substituted enamides and stereoselective reduction thereof Grant 7,629,470 - Campos , et al. December 8, 2 | 2009-12-08 |
Tyrosine kinase inhibitors App 20090182002 - Avalle; Paolo ;   et al. | 2009-07-16 |
Synthesis and Crystalline Forms of Npy5 Antagonist App 20090124648 - Ferlita; Russell R. ;   et al. | 2009-05-14 |
Formation of Tetra-Substituted Enamides and Stereoselective Reduction Thereof App 20090018340 - Campos; Kevin R. ;   et al. | 2009-01-15 |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor App 20080227786 - Ferlita; Russell R. ;   et al. | 2008-09-18 |
Amine salts of an integrin receptor antagonist Grant 7,074,930 - Wells , et al. July 11, 2 | 2006-07-11 |
Solid forms of slats with tyrosine kinase activity App 20050113577 - Karki, Shyam B ;   et al. | 2005-05-26 |
Amine salts of an integrin receptor antagonist App 20040249158 - Wells, Kenneth M ;   et al. | 2004-12-09 |
Hydrohalide salts of an HIV protease inhibitor App 20030125336 - Fleitz, Fred J. ;   et al. | 2003-07-03 |
Novel Crystalline Forms Of An Integrin Receptor Antagonist App 20020188001 - Xu, Wei ;   et al. | 2002-12-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.